Involuntary treatment saved me, and I never would have gotten my condition under control without medication. But the mental ...

No individual antipsychotic was associated with better cognitive outcomes than placebo in patients with schizophrenia spectrum disorders (SSD), according to a systematic review an ...

Cobenfy's journey from the lab through regulatory approval is a case study in how America's world-class scientists work to ...

Scientists now have greater insight into one of Schizophrenia's poorly understood hallmarks — auditory hallucinations.

For the first time in nearly 30 years, the U.S. Food and Drug Administration has approved a new drug treating schizophrenia, ...

Bristol-Myers’ newly approved schizophrenia treatment might be coming full circle.

Off the scrapheap of discarded drugs and on its way to becoming the most highly anticipated approval of 2024, Bristol Myers ...

Many researchers believe that schizophrenia can affect a person's ability to smell and how they perceive smells. However, the ...

Popular depictions of schizophrenia often focus on visual hallucinations, but auditory hallucinations are far more common. At ...

AbbVie's acquisition of Cerevel Therapeutics strengthens its neuroscience pipeline with promising candidates, making ABBV a ...

Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture its ...